Bicara Therapeutics Inc. Common Stock (BCAX) — Net Asset Quality Index
Bicara Therapeutics Inc. Common Stock (BCAX) has a Net Asset Quality Index of 91.5% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $512.24 Million minus total liabilities of $43.48 Million yields net assets of $468.77 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read debt load of Bicara Therapeutics Inc. Common Stock for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Bicara Therapeutics Inc. Common Stock Net Asset Quality Index Over Time (2022–2025)
This chart shows how Bicara Therapeutics Inc. Common Stock's Net Asset Quality Index has evolved across 4 annual periods from 2022 to 2025. As of June 2026, the index stands at 91.5%, representing net assets of $468.77 Million against total assets of $512.24 Million USD. For live market cap and overall valuation, see Bicara Therapeutics Inc. Common Stock stock valuation.
Annual Net Asset Quality Index for Bicara Therapeutics Inc. Common Stock (2022–2025)
The table below presents the year-by-year Net Asset Quality Index for Bicara Therapeutics Inc. Common Stock from 2022 to 2025, covering 4 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check Bicara Therapeutics Inc. Common Stock PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 93.1% | $401.45 Million | $430.99 Million | $29.54 Million | ▲ +6.7 pp |
| 2024 | 86.4% | $491.88 Million | $569.20 Million | $77.32 Million | ▼ -7.0 pp |
| 2023 | 93.4% | $218.51 Million | $233.98 Million | $15.47 Million | ▲ +351.2 pp |
| 2022 | -257.8% | $-17.28 Million | $6.70 Million | $23.98 Million | — |